首页> 外文期刊>Nature >Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
【24h】

Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

机译:与拮抗剂结合的人M2毒蕈碱型乙酰胆碱受体的结构

获取原文
获取原文并翻译 | 示例
       

摘要

The parasympathetic branch of the autonomic nervous system regulates the activity of multiple organ systems. Muscarinic receptors are G-protein-coupled receptors that mediate the response to acetylcholine released from parasympathetic nerves~(1-5). Their role in the unconscious regulation of organ and central nervous system function makes them potential therapeutic targets for a broad spectrum of diseases. The M2 muscarinic acetylcholine receptor (M2 receptor) is essential for the physiological control of cardiovascular function through activation of G-protein-coupled inwardly rectifying potassium channels, and is of particular interest because of its extensive pharmacological characterization with both orthosteric and allosteric ligands. Here we report the structure of the antagonist-bound human M2 receptor, the first human acetylcholine receptor to be characterized structurally, to our knowledge. The antagonist 3-quinuclidinyl-benzilate binds in the middle of a long aqueous channel extending approximately two-thirds through the membrane. The orthosteric binding pocket is formed by amino adds that are identical in all five muscarinic receptor subtypes, and shares structural homology with other functionally unrelated acetylcholine binding proteins from different species. A layer of tyrosine residues forms an aromatic cap restricting dissociation of the bound ligand. A binding site for allosteric ligands has been mapped to residues at the entrance to the binding pocket near this aromatic cap. The structure of the M2 receptor provides insights into the challenges of developing subtype-selective ligands for muscarinic receptors and their propensity for allosteric regulation.
机译:自主神经系统的副交感神经分支调节多个器官系统的活动。毒蕈碱受体是G蛋白偶联受体,介导副交感神经释放对乙酰胆碱的反应[1-5]。它们在无意识调节器官和中枢神经系统功能中的作用使其成为广泛疾病的潜在治疗靶标。 M2毒蕈碱型乙酰胆碱受体(M2受体)对于激活G蛋白偶联的内向整流钾通道,对心血管功能的生理控制至关重要,由于其具有正构和变构配体的广泛药理学特性,因此特别受关注。在此,据我们所知,我们报道了结合受体的人类M2受体的结构,这是第一个在结构上得到表征的人类乙酰胆碱受体。拮抗剂3-奎宁环烷基-苯甲酸酯在长的水通道的中间结合,延伸穿过膜约三分之二。正构结合口袋由在所有五个毒蕈碱受体亚型中相同的氨基添加物形成,并与来自不同物种的其他功能无关的乙酰胆碱结合蛋白具有结构同源性。酪氨酸残基层形成限制结合的配体解离的芳族帽。别构配体的结合位点已定位到该芳香帽附近结合口袋入口处的残基。 M2受体的结构提供了对开发毒蕈碱受体亚型选择性配体的挑战及其变构调节倾向的见解。

著录项

  • 来源
    《Nature》 |2012年第7386期|p.547-551|共5页
  • 作者单位

    Department of Life Science, Faculty of Science, Gakushuin University, Mejiro 1-5-1,Tokyo 171-8588, Japan;

    Department of Molecularand Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford,California 94305, USA;

    Department of Medical Chemistry and Cell Biology, Kyoto University Faculty of Medicine, Konoe-cho,Yoshdida,Sakyo-Ku, Kyoto 606-8501, Japan,Human ReceptorCrystallography Project, ERATO, Japan Science and Technology Agency, Konoe-cho, Yoshida,Sakyo-Ku, Kyoto 606-8501, Japan;

    Department of Medical Chemistry and Cell Biology, Kyoto University Faculty of Medicine, Konoe-cho,Yoshdida,Sakyo-Ku, Kyoto 606-8501, Japan,Human ReceptorCrystallography Project, ERATO, Japan Science and Technology Agency, Konoe-cho, Yoshida,Sakyo-Ku, Kyoto 606-8501, Japan;

    Human ReceptorCrystallography Project, ERATO, Japan Science and Technology Agency, Konoe-cho, Yoshida,Sakyo-Ku, Kyoto 606-8501, Japan,Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan;

    Department of Molecularand Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford,California 94305, USA;

    Department of Molecularand Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford,California 94305, USA,Department of Structural Biology, Stanford University School of Medicine, 299 Campus Drive, Stanford, California 94305, USA.;

    Department of Life Science, Faculty of Science, Gakushuin University, Mejiro 1-5-1,Tokyo 171-8588, Japan;

    Department of Molecularand Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford,California 94305, USA;

    Department of Life Science, Faculty of Science, Gakushuin University, Mejiro 1-5-1,Tokyo 171-8588, Japan;

    Department of Medical Chemistry and Cell Biology, Kyoto University Faculty of Medicine, Konoe-cho,Yoshdida,Sakyo-Ku, Kyoto 606-8501, Japan,Human ReceptorCrystallography Project, ERATO, Japan Science and Technology Agency, Konoe-cho, Yoshida,Sakyo-Ku, Kyoto 606-8501, Japan,Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), Kyoto University Faculty of Medicine, Kyoto 606-8501, Japan;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:58

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号